Advisors to FCF

Dr. John Craig and Dr. Lola Reid are the lead medical/scientific advisors for FCF. In addition, listed below are leading physicians, scientists and researchers who deal with fibrolamellar hepatocellular carcinoma and have agreed to be advisors to FCF. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer. It is from this group of advisors, under the guidance of Dr. Craig and Dr. Reid, that FCF puts together committees to review requests for grants.


Ghassan Abou-Alfa, M.D.

Attending Physician
Department of Medicine and Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center, New York


Nabeel Bardeesy, Ph.D.

Associate Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Cancer Center


Kevin C. Barry, Ph.D.

Postdoctoral Scholar
Department of Pathology
University of California, San Francisco


Nancy Carrasco, M.D.

Department of Cellular and Molecular Physiology
Yale School of Medicine


Michael Choti, M.D., M.B.A.

Professor and Chairman
Department of Surgery
UT Southwestern Medical Center, Dallas, Texas


John Craig, M.D. , PhD
Pathologist, Director of FCF
Carmel, California


Ronald P. DeMatteo, M.D., FACS

Vice Chair, Department of Surgery
Head, Division of General Surgical Oncology

Memorial Sloan-Kettering Cancer Center, New York


Anna Mae Diehl, M.D.

Department of Medicine

Duke University


Ephraim Fuchs, M.D.

Professor of Oncology and Immunology
Johns Hopkins University

John Gordon, M.D., Ph.D.

Clinical Instructor, Oncology
GI Oncology Group and Shokat Laboratory

University of California, San Francisco


Tim Greten, M.D.

Senior Investigator
Thoracic and Gastrointestinal Oncology Branch

National Cancer Institute


Yi Guo, Ph.D.

Associate Consultant and Assistant Professor
Biochemistry and Molecular Biology

Mayo Clinic, Rochester MN


Cynthia D. Guy, M.D.

Associate Professor
Department of Pathology

Duke University


William Harris, M.D.

Associate Professor
Division of Oncology

University of Washington School of Medicine


Ahmed Kaseb, M.D.

Director of Hepatocellular Carcinoma Program
Department of Gastrointestinal Medical Oncology

University of Texas M.D. Anderson Cancer Center


Amy K. Kim, M.D.

Associate Professor of Medicine
Division of Gastroenterology/Hepatology

Johns Hopkins University


Olga Kozyreva, M.D.

Dana-Farber Cancer Institute


Michael P. LaQuaglia, M.D., FACS, FRCS

Chief, Pediatric Surgical Service
Memorial Sloan-Kettering Cancer Center, New York


Ron Levine, M.D.

Greenwich, Connecticut


Barbara Lyons, Ph.D.

Associate Professor
Department of Chemistry and Biochemistry

New Mexico State University


Mark McNiven, Ph.D.

George M. Eisenberg Professor
Biochemistry and Molecular Biology

Mayo Clinic, Rochester Minnesota


Sofia de Oliveira, Ph.D.

EMBO Postdoctoral Fellow
Department of Medical Microbiology and Immunology

University of Wisconsin-Madison


Hibba tul Rehman, M.D.

Chief Fellow
Division of Hematology/Oncology

University of Vermont


Lola Reid, Ph.D.

Department of Cell and Molecular Physiology
University of North Carolina, Chapel Hill, North Carolina


 Julien Sage, Ph.D.

Associate Professor
Pediatrics (Hematology/Oncology) and of Genetics
Stanford University


Praveen Sethupathy, Ph.D.

Assistant Professor
Department of Genetics
University of North Carolina, Chapel Hill



Shimon Slavin, M.D.

The International Center for Cell Therapy & Cancer Immunotheraphy (CTCI)
Tel Aviv, Israel


Kevin M. Sullivan, M.D.

R3/General Surgery
University of Washington


Michael Torbenson, M.D.

Senior Associate Consultant
Department of Anatomic Pathology
Mayo Clinic, Rochester, Minnesota


Jean-Nicholas Vauthey, M.D.

Department of Surgical Oncology
University of Texas MD Anderson Cancer Center


Alan P. Venook, M.D.

Department of Medicine (Hematology/Oncology)
University of California, San Francisco



Yuzhuo Wang, Ph.D.

University of British Columbia Cancer Center